Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies ; volume:9 ; number:10 ; day:17 ; month:9 ; year:2018 ; pages:1-16 ; date:10.2018
Cell death & disease ; 9, Heft 10 (17.9.2018), 1-16, 10.2018
- Creator
-
Rosati, Jessica
- Contributor
-
Ferrari, Daniela
Altieri, Filomena
Tardivo, Silvia
Ricciolini, Claudia
Fusilli, Caterina
Zalfa, Cristina
Profico, Daniela C.
Pinos, Francesca
Bernardini, Laura
Torres, Barbara
Manni, Isabella
Piaggio, Giulia
Binda, Elena
Copetti, Massimiliano
Lamorte, Giuseppe
Mazza, Tommaso
Carella, Massimo
Gelati, Maurizio
Valente, Enza Maria
Simeone, Antonio
Vescovi, Angelo L.
SpringerLink (Online service)
- DOI
-
10.1038/s41419-018-0990-2
- URN
-
urn:nbn:de:101:1-2018110315195960330985
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rosati, Jessica
- Ferrari, Daniela
- Altieri, Filomena
- Tardivo, Silvia
- Ricciolini, Claudia
- Fusilli, Caterina
- Zalfa, Cristina
- Profico, Daniela C.
- Pinos, Francesca
- Bernardini, Laura
- Torres, Barbara
- Manni, Isabella
- Piaggio, Giulia
- Binda, Elena
- Copetti, Massimiliano
- Lamorte, Giuseppe
- Mazza, Tommaso
- Carella, Massimo
- Gelati, Maurizio
- Valente, Enza Maria
- Simeone, Antonio
- Vescovi, Angelo L.
- SpringerLink (Online service)
Other Objects (12)
Establishment of Stable Cell Line for Inducing Kap1 Protein Expression
Microencapsulation-based cell therapies
Cell therapies for pancreatic beta-cell replenishment
Cell-Based Therapies with T Regulatory Cells
A core–shell microneedle system for stable fibroblast delivery in cell-based therapies
Establishment of a murine epidermal cell line suitable for in vitro and in vivo skin modelling
Establishment of a clinically applicable stable packaging cell line for alpharetroviral SIN vectors
Genome-Edited T Cell Therapies
Advances in neonatal cell therapies: Proceedings of the First Neonatal Cell Therapies Symposium (2022)
Establishment and Application of Engineered NIH 3T3 Cell Line with Stable Human RAGE Expression
Clinical trials for stem cell therapies
Emerging therapies in mantle cell lymphoma
Establishment of Stable Cell Line for Inducing Kap1 Protein Expression
Microencapsulation-based cell therapies
Cell therapies for pancreatic beta-cell replenishment
Cell-Based Therapies with T Regulatory Cells
A core–shell microneedle system for stable fibroblast delivery in cell-based therapies
Establishment of a murine epidermal cell line suitable for in vitro and in vivo skin modelling
Establishment of a clinically applicable stable packaging cell line for alpharetroviral SIN vectors
Genome-Edited T Cell Therapies
Advances in neonatal cell therapies: Proceedings of the First Neonatal Cell Therapies Symposium (2022)
Establishment and Application of Engineered NIH 3T3 Cell Line with Stable Human RAGE Expression
Clinical trials for stem cell therapies
Emerging therapies in mantle cell lymphoma
Establishment of Stable Cell Line for Inducing Kap1 Protein Expression
Microencapsulation-based cell therapies
Cell therapies for pancreatic beta-cell replenishment
Cell-Based Therapies with T Regulatory Cells
A core–shell microneedle system for stable fibroblast delivery in cell-based therapies
Establishment of a murine epidermal cell line suitable for in vitro and in vivo skin modelling
Establishment of a clinically applicable stable packaging cell line for alpharetroviral SIN vectors
Genome-Edited T Cell Therapies
Advances in neonatal cell therapies: Proceedings of the First Neonatal Cell Therapies Symposium (2022)
Establishment and Application of Engineered NIH 3T3 Cell Line with Stable Human RAGE Expression
Clinical trials for stem cell therapies